MwanzoGUD • TSE
add
Knight Therapeutics Inc
Bei iliyotangulia
$ 6.03
Bei za mwaka
$ 5.11 - $ 6.55
Thamani ya kampuni katika soko
598.54M CAD
Wastani wa hisa zilizouzwa
elfu 51.86
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
TSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CAD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 121.55M | 31.74% |
Matumizi ya uendeshaji wa biashara | 55.16M | 31.93% |
Mapato halisi | -3.79M | -4,560.00% |
Kiwango cha faida halisi | -3.12 | -3,566.67% |
Mapato kwa kila hisa | -0.02 | — |
EBITDA | 18.41M | 10.98% |
Asilimia ya kodi ya mapato | -97.76% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CAD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 118.14M | -31.44% |
Jumla ya mali | 1.05B | 8.97% |
Jumla ya dhima | 281.78M | 49.58% |
Jumla ya hisa | 766.79M | — |
hisa zilizosalia | 99.29M | — |
Uwiano wa bei na thamani | 0.78 | — |
Faida inayotokana na mali | 0.15% | — |
Faida inayotokana mtaji | 0.19% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CAD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -3.79M | -4,560.00% |
Pesa kutokana na shughuli | 10.16M | 102.61% |
Pesa kutokana na uwekezaji | -1.41M | -112.20% |
Pesa kutokana na ufadhili | -5.91M | -50.47% |
Mabadiliko halisi ya pesa taslimu | 4.06M | -68.64% |
Mtiririko huru wa pesa | -3.92M | -484.53% |
Kuhusu
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Ilianzishwa
2014
Makao Makuu
Tovuti
Wafanyakazi
745
